Literature DB >> 7492768

Granulomonocyte-associated lysosomal protein expression during in vitro expansion and differentiation of CD34+ hematopoietic progenitor cells.

C Scheinecker1, H Strobl, G Fritsch, B Csmarits, O Krieger, O Majdic, W Knapp.   

Abstract

Using an in vitro expansion and differentiation system for human CD34+ cord blood (CB) progenitor cells, we analyzed the induction and expression kinetics of the granulomonocyte associated lysosomal proteins myeloperoxidase (MPO), lysozyme (LZ), lactoferrin (LF), and macrosialin (CD68). Freshly isolated CD34+ CB cells were negative for LZ and LF, and only small proportions expressed MPO (4% +/- 2%) or CD68 (3% +/- 1%). Culturing of CD34+ cells for 14 days with interleukin (IL)-1, IL-3, IL-6, stem cell factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and G-CSF resulted in on average a 1,750-fold amplification of cell number, of which 83% +/- 7% were MPO+. Without addition of GM-CSF and G-CSF, lower increases in total cell numbers (mean, 211-fold) and lower proportions of MPO+ cells (54% +/- 11%) were observed. The proportion of MPO+ cells slightly exceeded but clearly correlated with the proportion of cells positive for the granulomonocyte associated surface molecules CD11b (Mac-1), CD15 (LeX), CD64 (Fc gamma RI) CD66, or CD89 (Fc alpha R). At day 14 MPO+ and LZ+ cells were virtually identical. However, at earlier time points during culture (days 4 and 7), single MPO+ or LZ+ cell populations were also observed, which only later acquired LZ and MPO, respectively. Maturation of cells into the neutrophilic pathway was indicated by the acquisition of MPO, followed by LZ. In contrast, maturation of cells into the monocytic pathway was indicated by the acquisition of LZ followed by MPO and CD14. CD68 was found to be expressed at day 4 by the majority of cells and was not restricted to the granulomonocytic cells, as cells with megakariocytic (CD41+) or erythroid (CD71hi) features were CD68+. LF expression was observed only in GM- plus G-CSF-supplemented cultures, in which only 26% +/- 5% of cells expressed LF by day 14.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7492768

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  5 in total

1.  Conditional gene targeting in macrophages and granulocytes using LysMcre mice.

Authors:  B E Clausen; C Burkhardt; W Reith; R Renkawitz; I Förster
Journal:  Transgenic Res       Date:  1999-08       Impact factor: 2.788

2.  Development, characterization, and technical applications of a fish lysozyme-specific monoclonal antibody (mAb M24-2).

Authors:  Marlee B Marsh; Charles D Rice
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2009-11-08       Impact factor: 2.268

3.  Coexpression of CD71 and CD117 Identifies an Early Unipotent Neutrophil Progenitor Population in Human Bone Marrow.

Authors:  Huy Q Dinh; Tobias Eggert; Melissa A Meyer; Yanfang Peipei Zhu; Claire E Olingy; Ryan Llewellyn; Runpei Wu; Catherine C Hedrick
Journal:  Immunity       Date:  2020-08-18       Impact factor: 31.745

4.  Monocytic cell differentiation from band-stage neutrophils under inflammatory conditions via MKK6 activation.

Authors:  René Köffel; Anastasia Meshcheryakova; Joanna Warszawska; Annika Hennig; Karin Wagner; Almut Jörgl; Daniela Gubi; Doris Moser; Anastasiya Hladik; Ulrike Hoffmann; Michael B Fischer; Wim van den Berg; Marije Koenders; Clemens Scheinecker; Bernhard Gesslbauer; Sylvia Knapp; Herbert Strobl
Journal:  Blood       Date:  2014-09-11       Impact factor: 22.113

5.  The zebrafish lysozyme C promoter drives myeloid-specific expression in transgenic fish.

Authors:  Chris Hall; Maria Vega Flores; Thilo Storm; Kathy Crosier; Phil Crosier
Journal:  BMC Dev Biol       Date:  2007-05-04       Impact factor: 1.978

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.